CD44-targeting hydrophobic phosphorylated gemcitabine prodrug nanotherapeutics augment lung cancer therapy
Beibei Guo, Jingjing Wei, Jingyi Wang, Yinping Sun, Jiandong Yuan, Zhiyuan Zhong, Fenghua Meng
Topics & Concepts
GemcitabineProdrugCD44BioavailabilityPharmacologyCancer researchMicelleChemistryMedicineChemotherapyInternal medicineCellBiochemistryAqueous solutionPhysical chemistryLung Cancer Research StudiesPeptidase Inhibition and AnalysisCancer Cells and Metastasis